MYCN and neuroblastoma: Genome-wide analyses of DNA methylation revealed both established and novel DNA methylated regions, such as telomeric silencing and identified subgroups in NB, correlating with specific genetic and clinical features, such as age, stage, MYCN amplification, and immune infiltration [141,142,143,144].